$7.847.84 -0.30-0.30 |(-3.69-3.69 %)
52W H: 73.0652W L: 7.68Beta: 1.20
About Atrium Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
Frequently Asked Questions
What is the 52-week range for RNA?
The 52-week high is $73.06 and the 52-week low is $7.68.
What is the P/E ratio for RNA?
The P/E ratio data is currently unavailable.
What is the dividend yield for RNA?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -40.30%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -209.23%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.76.
Analyst Recommendation Trends
Wall Street analyst consensus for RNA over the last few months:
2026-09-01
Buy: 5
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 4
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 3
S.Buy: 1
Hold: 1
Sell: 0
Latest RNA News
Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Atrium Therapeutics, Inc. (Nasdaq: RNA) (the "Company") today announced it awarded inducement grants on September 20, 2026 under the Company's 2026 Employment Inducement Incentive Award Plan (the "2026 Inducement Plan") as a material inducement to the employment of one non-executive individual newly hired by the Company.
Yahoo9/21/2026
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's regular session. The market value of their outstanding shares is at $162.5 million. PDS Biotechnology (NASDAQ:PDSB)
Benzinga9/8/2026
Wall Street Money Is Leaving Just As Atrium’s (RNA) Pipeline Turns Real
On August 13, Atrium Therapeutics (NASDAQ:RNA) reported second-quarter 2026 results that mixed real clinical progress with a familiar biotech question: how long the cash lasts. The company disclosed FDA clearance of its IND application for ATR 1072 and the launch of Corventis, its first Phase 1/2 trial and the first study anywhere testing a disease-modifying […]
Yahoo9/6/2026
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-18 | Younis Husam | -11,216 | $8.95 | $100,383 |
| 2026-09-18 | Kenney Stephanie | -2,375 | $8.95 | $21,256 |
| 2026-09-18 | Winslow Brendan R. | -6,742 | $8.95 | $60,341 |
| 2026-09-18 | Hoyos Rocio Martin | -8,320 | $8.95 | $74,464 |
| 2026-09-18 | Gallagher Kathleen P. | -11,632 | $8.95 | $104,106 |
| 2026-09-18 | Flanagan W. Michael | -22,812 | $8.95 | $204,167 |
| 2026-09-18 | Hughes Steven George | -21,459 | $8.95 | $192,058 |
| 2026-09-18 | Boyce Sarah | -126,418 | $8.95 | $1,131,441 |
| 2026-04-20 | Kenney Stephanie | +60,000 | - | - |
| 2026-04-20 | Kenney Stephanie | +30,000 | - | - |
| 2026-04-20 | Winslow Brendan R. | +60,000 | - | - |
| 2026-04-20 | Winslow Brendan R. | +30,000 | - | - |
| 2026-04-20 | Hoyos Rocio Martin | +60,000 | - | - |
| 2026-04-20 | Hoyos Rocio Martin | +30,000 | - | - |
| 2026-04-20 | Younis Husam | +60,000 | - | - |
| 2026-04-20 | Younis Husam | +30,000 | - | - |
| 2026-04-20 | Gallagher Kathleen P. | +205,000 | - | - |
| 2026-04-20 | Gallagher Kathleen P. | +102,500 | - | - |
| 2026-04-20 | Hughes Steven George | +60,000 | - | - |
| 2026-04-20 | Hughes Steven George | +30,000 | - | - |
| 2026-02-27 | Boyce Sarah | -165,000 | - | - |
| 2026-02-27 | Boyce Sarah | -300,000 | - | - |
| 2026-02-27 | Boyce Sarah | -200,000 | - | - |
| 2026-02-27 | Boyce Sarah | -400,000 | - | - |
| 2026-02-27 | Boyce Sarah | -425,000 | - | - |
| 2026-02-27 | Boyce Sarah | -300,000 | - | - |
| 2026-02-27 | Boyce Sarah | -386,015 | - | - |
| 2026-02-27 | Boyce Sarah | -474,861 | - | - |
| 2026-02-27 | McCarthy Teresa | -50,000 | - | - |
| 2026-02-27 | McCarthy Teresa | -78,000 | - | - |
| 2026-02-27 | McCarthy Teresa | -54,000 | - | - |
| 2026-02-27 | McCarthy Teresa | -108,000 | - | - |
| 2026-02-27 | McCarthy Teresa | -57,500 | - | - |
| 2026-02-27 | McCarthy Teresa | -65,000 | - | - |
| 2026-02-27 | McCarthy Teresa | -106,000 | - | - |
| 2026-02-27 | McCarthy Teresa | -165,296 | - | - |
| 2026-02-27 | Thompson Tamar | -22,000 | - | - |
| 2026-02-27 | Thompson Tamar | -22,000 | - | - |
| 2026-02-27 | Thompson Tamar | -13,489 | - | - |
| 2026-02-27 | Thompson Tamar | -10,034 | - | - |
| 2026-02-27 | Thompson Tamar | -6,692 | - | - |
| 2026-02-27 | Skerjanec Simona | -42,308 | - | - |
| 2026-02-27 | Skerjanec Simona | -10,034 | - | - |
| 2026-02-27 | Skerjanec Simona | -6,692 | - | - |
| 2026-02-27 | Hughes Steven George | -50,000 | - | - |
| 2026-02-27 | Hughes Steven George | -68,458 | - | - |
| 2026-02-27 | Hughes Steven George | -49,333 | - | - |
| 2026-02-27 | Hughes Steven George | -74,000 | - | - |
| 2026-02-27 | Hughes Steven George | -73,342 | - | - |
| 2026-02-27 | Hughes Steven George | -115,857 | - | - |
| 2026-02-27 | Flanagan W. Michael | -50,000 | - | - |
| 2026-02-27 | Flanagan W. Michael | -88,000 | - | - |
| 2026-02-27 | Flanagan W. Michael | -72,000 | - | - |
| 2026-02-27 | Flanagan W. Michael | -96,000 | - | - |
| 2026-02-27 | Flanagan W. Michael | -66,500 | - | - |
| 2026-02-27 | Flanagan W. Michael | -25,000 | - | - |
| 2026-02-27 | Flanagan W. Michael | -150,365 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -50,000 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -16,000 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -13,520 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -42,480 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -27,584 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -13,352 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -9,244 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -13,829 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -22,321 | - | - |
| 2026-02-27 | Gallagher Kathleen P. | -80,303 | - | - |
| 2026-02-27 | Henig Noreen | -9,534 | - | - |
| 2026-02-27 | Henig Noreen | -11,323 | - | - |
| 2026-02-27 | Henig Noreen | -15,000 | - | - |
| 2026-02-27 | Henig Noreen | -22,000 | - | - |
| 2026-02-27 | Henig Noreen | -22,000 | - | - |
| 2026-02-27 | Henig Noreen | -13,489 | - | - |
| 2026-02-27 | Henig Noreen | -10,034 | - | - |
| 2026-02-27 | Henig Noreen | -6,692 | - | - |
| 2026-02-27 | Kim Jean Jinsun | -30,000 | - | - |
| 2026-02-27 | Kim Jean Jinsun | -22,000 | - | - |
| 2026-02-27 | Kim Jean Jinsun | -22,000 | - | - |
| 2026-02-27 | Kim Jean Jinsun | -13,489 | - | - |
| 2026-02-27 | Kim Jean Jinsun | -10,034 | - | - |
| 2026-02-27 | Kim Jean Jinsun | -6,692 | - | - |
| 2026-02-27 | Mosbrooker Eric | -50,000 | - | - |
| 2026-02-27 | Mosbrooker Eric | -177,188 | - | - |
| 2026-02-27 | Mosbrooker Eric | -79,413 | - | - |
| 2026-02-27 | Calderaro Charles III | -80,000 | - | - |
| 2026-02-27 | Calderaro Charles III | -98,547 | - | - |
| 2026-02-27 | WILSON TROY EDWARD | -15,000 | - | - |
| 2026-02-27 | WILSON TROY EDWARD | -13,489 | - | - |
| 2026-02-27 | WILSON TROY EDWARD | -10,034 | - | - |
| 2026-02-27 | WILSON TROY EDWARD | -13,711 | - | - |
| 2026-02-27 | WILSON TROY EDWARD | -65,091 | - | - |
| 2026-02-27 | Moriarty John B | -160,000 | - | - |
| 2026-02-27 | Moriarty John B | -50,000 | - | - |
| 2026-02-27 | Moriarty John B | -92,054 | - | - |
| 2026-02-27 | Kaye Edward M. MD | -9,534 | - | - |
| 2026-02-27 | Kaye Edward M. MD | -11,323 | - | - |
| 2026-02-27 | Kaye Edward M. MD | -15,000 | - | - |
| 2026-02-27 | Kaye Edward M. MD | -22,000 | - | - |
| 2026-02-27 | Kaye Edward M. MD | -22,000 | - | - |
| 2026-02-27 | Kaye Edward M. MD | -13,489 | - | - |
| 2026-02-27 | Kaye Edward M. MD | -10,034 | - | - |
| 2026-02-27 | Kaye Edward M. MD | -6,692 | - | - |
| 2026-02-27 | MacLean Michael F | -50,000 | - | - |
| 2026-02-27 | MacLean Michael F | -106,000 | - | - |
| 2026-02-27 | MacLean Michael F | -60,125 | - | - |
| 2026-02-27 | MacLean Michael F | -148,000 | - | - |
| 2026-02-27 | MacLean Michael F | -131,250 | - | - |
| 2026-02-27 | MacLean Michael F | -92,000 | - | - |
| 2026-02-27 | MacLean Michael F | -133,977 | - | - |
| 2026-02-27 | BOESS CARSTEN | -20,858 | - | - |
| 2026-02-27 | BOESS CARSTEN | -15,000 | - | - |
| 2026-02-27 | BOESS CARSTEN | -22,000 | - | - |
| 2026-02-27 | BOESS CARSTEN | -22,000 | - | - |
| 2026-02-27 | BOESS CARSTEN | -13,489 | - | - |
| 2026-02-27 | BOESS CARSTEN | -10,034 | - | - |
| 2026-02-27 | BOESS CARSTEN | -6,692 | - | - |
| 2026-02-27 | LEVIN ARTHUR A | -12,500 | - | - |
| 2026-02-27 | LEVIN ARTHUR A | -115,500 | - | - |
| 2026-02-27 | LEVIN ARTHUR A | -144,000 | - | - |
| 2026-02-27 | LEVIN ARTHUR A | -13,489 | - | - |
| 2026-02-27 | LEVIN ARTHUR A | -10,034 | - | - |
| 2026-02-27 | LEVIN ARTHUR A | -131,372 | - | - |
| 2026-02-27 | LEVIN ARTHUR A | -16,562 | - | - |
| 2026-01-21 | Hughes Steven George | -2,878 | $72.45 | $208,511 |
| 2026-01-21 | Hughes Steven George | -2,017 | $72.45 | $146,132 |
| 2026-01-21 | Boyce Sarah | -7,993 | $72.45 | $579,093 |
| 2026-01-21 | Boyce Sarah | -6,394 | $72.45 | $463,245 |
| 2026-01-21 | Flanagan W. Michael | -2,558 | $72.45 | $185,327 |
| 2026-01-21 | Flanagan W. Michael | -3,976 | $72.45 | $288,061 |
| 2026-01-21 | McCarthy Teresa | -1,453 | $72.45 | $105,270 |
| 2026-01-21 | McCarthy Teresa | -1,476 | $72.45 | $106,936 |
| 2026-01-21 | MacLean Michael F | -2,735 | $72.45 | $198,151 |
| 2026-01-21 | MacLean Michael F | -1,807 | $72.45 | $130,917 |
| 2026-01-21 | LEVIN ARTHUR A | -1,758 | $72.45 | $127,367 |
| 2026-01-07 | Boyce Sarah | -8,576 | $72.23 | $619,444 |
| 2026-01-07 | Calderaro Charles III | -3,727 | $72.23 | $269,201 |
| 2026-01-07 | McCarthy Teresa | -1,965 | $72.23 | $141,932 |
| 2026-01-07 | Hughes Steven George | -2,373 | $72.23 | $171,402 |
| 2026-01-07 | Flanagan W. Michael | -2,373 | $72.23 | $171,402 |
| 2026-01-07 | Moriarty John B | -2,374 | $72.23 | $171,474 |
| 2026-01-07 | MacLean Michael F | -1,974 | $72.23 | $142,582 |
| 2025-12-19 | LEVIN ARTHUR A | -1,330 | - | - |
| 2025-12-18 | Boyce Sarah | -29,159 | - | - |
| 2025-12-17 | Calderaro Charles III | -9,726 | $71.87 | $699,008 |
| 2025-12-17 | Calderaro Charles III | +23,250 | - | - |
| 2025-12-17 | Flanagan W. Michael | -13,695 | $71.87 | $984,260 |
| 2025-12-17 | Flanagan W. Michael | +27,500 | - | - |
| 2025-12-17 | Mosbrooker Eric | -11,426 | $71.87 | $821,187 |
| 2025-12-17 | Mosbrooker Eric | -36,564 | $71.87 | $2,627,855 |
| 2025-12-17 | Mosbrooker Eric | +72,000 | - | - |
| 2025-12-17 | Boyce Sarah | -15,742 | $71.87 | $1,131,378 |
| 2025-12-17 | Boyce Sarah | +31,000 | - | - |
| 2025-12-17 | Gallagher Kathleen P. | -8,030 | $71.87 | $577,116 |
| 2025-12-17 | Gallagher Kathleen P. | -33,336 | $71.87 | $2,395,858 |
| 2025-12-17 | Gallagher Kathleen P. | +72,000 | - | - |
| 2025-12-17 | McCarthy Teresa | -17,298 | $71.87 | $1,243,207 |
| 2025-12-17 | McCarthy Teresa | +39,000 | - | - |
| 2025-12-17 | Moriarty John B | -26,824 | $71.87 | $1,927,841 |
| 2025-12-17 | Moriarty John B | +56,000 | - | - |
| 2025-10-22 | Hughes Steven George | -2,209 | - | - |
| 2025-10-22 | Hughes Steven George | -2,209 | $47.5394 | $105,015 |
| 2025-10-22 | Hughes Steven George | +2,209 | $10.16 | $22,443 |
| 2025-10-15 | McCarthy Teresa | -20,000 | - | - |
| 2025-10-15 | McCarthy Teresa | -20,000 | $50.1529 | $1,003,058 |
| 2025-10-15 | McCarthy Teresa | +20,000 | $22.34 | $446,800 |